Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?

[1]  K. Ott,et al.  Prognostic impact of nodal status and therapeutic implications. , 2017, Translational gastroenterology and hepatology.

[2]  G. Verlato,et al.  Western strategy for EGJ carcinoma , 2017, Gastric Cancer.

[3]  N. Rizk.  Gastroesophageal Junction Tumors , 2016, Annals of Surgical Oncology.

[4]  E. Kwak,et al.  What’s the Best Way to Treat GE Junction Tumors? Approach Like Gastric Cancer , 2016, Annals of Surgical Oncology.

[5]  S. Friesland,et al.  A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  J. Wain,et al.  Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy. , 2016, The Annals of thoracic surgery.

[7]  J. Ajani,et al.  Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ? , 2016, Annals of Surgical Oncology.

[8]  W. Weichert,et al.  Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[9]  D. Jäger,et al.  Surgery of gastric cancer and esophageal cancer: Does age matter? , 2015, Journal of surgical oncology.

[10]  M. Ebert,et al.  International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus , 2015, Gastric Cancer.

[11]  C. Yeo,et al.  Minimally invasive esophagectomy provides significant survival advantage compared with open or hybrid esophagectomy for patients with cancers of the esophagus and gastroesophageal junction. , 2015, Journal of the American College of Surgeons.

[12]  P. Siersema,et al.  Surgical Treatment of Adenocarcinomas of the Gastro-esophageal Junction , 2015, Annals of Surgical Oncology.

[13]  T. Yoshikawa,et al.  Ten‐year follow‐up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia , 2015, The British journal of surgery.

[14]  R. van Hillegersberg,et al.  Systematic review of the surgical strategies of adenocarcinomas of the gastroesophageal junction. , 2014, Surgical oncology.

[15]  R. Langer,et al.  Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas , 2014, British Journal of Cancer.

[16]  M. Krasna,et al.  Prognostic significance of positive circumferential resection margin in esophageal cancer: a systematic review and meta-analysis. , 2014, The Annals of thoracic surgery.

[17]  W. Lewis,et al.  Systematic review and meta‐analysis of the influence of circumferential resection margin involvement on survival in patients with operable oesophageal cancer , 2013, The British journal of surgery.

[18]  G. Sauter,et al.  Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction , 2012, The British journal of surgery.

[19]  V. V. van Berkel,et al.  Management of gastroesophageal junction tumors. , 2012, The Surgical clinics of North America.

[20]  E W Steyerberg,et al.  Preoperative chemoradiotherapy for esophageal or junctional cancer. , 2012, The New England journal of medicine.

[21]  H. Daiko,et al.  Clinicopathological Features and Prognostic Factors of Adenocarcinoma of the Esophagogastric Junction According to Siewert Classification: Experiences at a Single Institution in Japan , 2012, Annals of Surgical Oncology.

[22]  A. Egashira,et al.  Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection , 2012, Surgery Today.

[23]  V. Gebski,et al.  Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. , 2011, The Lancet. Oncology.

[24]  R. Langer,et al.  Significance of Histopathological Tumor Regression After Neoadjuvant Chemotherapy in Gastric Adenocarcinomas: A Summary of 480 Cases , 2011, Annals of surgery.

[25]  T. Yoshikawa,et al.  Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies , 2010, Gastric Cancer.

[26]  M. Stuschke,et al.  Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  M. Feith,et al.  Surgical Factors Influence the Outcome After Ivor-Lewis Esophagectomy with Intrathoracic Anastomosis for Adenocarcinoma of the Esophagogastric Junction: A Consecutive Series of 240 Patients at an Experienced Center , 2009, Annals of Surgical Oncology.

[28]  I. Sperduti,et al.  Adenocarcinoma of the Esophagogastric Junction: The Role of Abdominal-Transhiatal Resection , 2009, Annals of Surgical Oncology.

[29]  M. Büchler,et al.  Fundus Rotation Gastroplasty vs. Kirschner-Akiyama Gastric Tube in Esophageal Resection: Comparison of Perioperative and Long-Term Results , 2008, World Journal of Surgery.

[30]  J. Johansson,et al.  Two Different Surgical Approaches in the Treatment of Adenocarcinoma at the Gastroesophageal Junction , 2008, World Journal of Surgery.

[31]  R. Malekzadeh,et al.  Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer , 2007, Gut.

[32]  D. Alderson,et al.  Health‐related quality of life among patients with adenocarcinoma of the gastro‐oesophageal junction treated by gastrectomy or oesophagectomy , 2007, The British journal of surgery.

[33]  F. Roviello,et al.  Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. , 2007, The Journal of thoracic and cardiovascular surgery.

[34]  V. Rusch,et al.  Adenocarcinoma of the Gastroesophageal Junction: Influence of Esophageal Resection Margin and Operative Approach on Outcome , 2007, Annals of surgery.

[35]  S. Vollset,et al.  Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status , 2007, Gut.

[36]  L. Lundell,et al.  Incidence of carcinoma of the oesophagus and gastric cardia. Changes over time and geographical differences. , 2007, Acta oncologica.

[37]  J. Siewert,et al.  Surgical management of esophagogastric junction tumors. , 2006, World journal of gastroenterology.

[38]  A. Nashimoto,et al.  Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. , 2006, The Lancet. Oncology.

[39]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[40]  S. Ashley,et al.  Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? , 2004, Journal of the American College of Surgeons.

[41]  P. D. De Leyn,et al.  Three-Field Lymphadenectomy for Carcinoma of the Esophagus and Gastroesophageal Junction in 174 R0 Resections: Impact on Staging, Disease-Free Survival, and Outcome: A Plea for Adaptation of TNM Classification in Upper-Half Esophageal Carcinoma , 2004, Annals of surgery.

[42]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[43]  H. Höfler,et al.  Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy , 2003, Cancer.

[44]  C. Mariette,et al.  Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[45]  C. Mariette,et al.  Surgical management of and long‐term survival after adenocarcinoma of the cardia , 2002, The British journal of surgery.

[46]  A. Hölscher,et al.  Topographical distribution of lymph node metastasis in adenocarcinoma of the gastroesophageal junction. , 2002, Hepato-gastroenterology.

[47]  M. Feith,et al.  Adenocarcinoma of the Esophagogastric Junction: Results of Surgical Therapy Based on Anatomical/Topographic Classification in 1,002 Consecutive Patients , 2000, Annals of surgery.

[48]  H. Stein,et al.  Classification of adenocarcinoma of the oesophagogastric junction , 1998, The British journal of surgery.

[49]  M. Schilling,et al.  A technique for gastroplasty as a substitute for the esophagus: fundus rotation gastroplasty. , 1996, Journal of the American College of Surgeons.

[50]  J. Fraumeni,et al.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.

[51]  H. Akiyama,et al.  Resection and reconstruction for carcinoma of the thoracic oesophagus , 1976, The British journal of surgery.

[52]  A. Hölscher,et al.  Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy? , 2015, Gastric Cancer.

[53]  J. Thigpen.  Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial , 2011 .